Soleno Therapeutics (SLNO)

• Market cap: $2.34B
• 1 day: -7.1%
• 5 days: -37.38%
• 1 month: -25.51%
• 3 months: -46.37%
• 6 months: -40.93%
• Year to date: -4.75%
• 1 year: -23.43%
• 5 years: 49.62%
• 10 years: -67.39%
• Sector: Healthcare
• Industry: Biotechnology

About: Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Employees: 133